Wordt geladen...
Charting the molecular network of the drug target Bcr-Abl
The tyrosine kinase Bcr-Abl causes chronic myeloid leukemia and is the cognate target of tyrosine kinase inhibitors like imatinib. We have charted the protein–protein interaction network of Bcr-Abl by a 2-pronged approach. Using a monoclonal antibody we have first purified endogenous Bcr-Abl protein...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
National Academy of Sciences
2009
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2670881/ https://ncbi.nlm.nih.gov/pubmed/19380743 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0900653106 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|